Nu-Med Plus (NUMD) Payables (2012 - 2025)

Nu-Med Plus has disclosed Payables across 14 years of filings, most recently posting $148203.0 for Q4 2025.

• Payables for Q4 2025 came in at $148203.0, up 3.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $148203.0 (up 3.61% YoY), and the FY2025 annual result was $148203.0, up 3.61% from the prior year.
• Payables came in at $148203.0 for Q4 2025 at Nu-Med Plus, roughly flat from $147847.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $155204.0 in Q2 2025 to a low of $12645.0 in Q1 2021.
• The 5-year median for Payables is $108208.5 (2022), against an average of $94245.9.
• Across the five-year window, Payables slumped 94.86% in 2021 and soared 286.36% in 2022, its largest moves.
• Nu-Med Plus' Payables stood at $27744.0 in 2021, then jumped by 286.36% to $107192.0 in 2022, then declined by 6.26% to $100478.0 in 2023, then soared by 42.36% to $143040.0 in 2024, then increased by 3.61% to $148203.0 in 2025.
• The last three Payables figures came in at $148203.0 (Q4 2025), $147847.0 (Q3 2025), and $155204.0 (Q2 2025), per Business Quant data.